Table 2 Germline pathogenic variantsĀ and somatic NF2 mutations and CNVs in the tumors.

From: Comparative clinical and genomic analysis of neurofibromatosis type 2-associated cranial and spinal meningiomas

Patient

Sex

Germline pathogenic variant

Number of spinal meningiomas

Number of cranial meningiomas

Somatic mutationĀ or CNV

P1

F

Nonsense, exon11, c.1021C > T, p.R341X

4

5

Chr22 LOH in all tumors

P2

F

Splice region, exon 2, c.241-9A > G

2

0

Chr22 LOH in both tumors

P3

F

Nonsense, exon2, c.193C > T, p.Q65X

0

3

Chr22 LOH in all tumors

P4

F

Nonsense, exon11, c.1030C > T, p.Q344X

3

0

Chr22 LOH in all tumors

P5

F

Splice site, exon4, c.447+1G > T

1

0

Chr22 LOH

P6

M

Nonsense, exon7, c.634C > T, p.Q212X

0

1

Chr22 LOH

P7

M

Nonsense, exon8, c.784C > T, p.R262X

0

1

Frameshift, exon12, c.1234delC, p.Q412fs

  1. LOH Loss of Heterozygosity.